Liposomes as vehicles for the presentation of a synthetic peptide containing an epitope of hepatitis A virus.

Previous work from our group showed that the entrapment of HAV-related synthetic peptides into multilamellar liposomes yielded satisfactory immunoresponses when administered to mice. In the present work we report investigative results for several liposome formulations of a 20-mer peptide related to VP3 capsid protein of HAV. In this sense, the recently introduced surface plasmon resonance technique has been applied to compare the different strategies of association between the synthetic peptide and phospholipid vesicles and to demonstrate that no significant alteration in antigenicity is produced when the peptide sequence is covalently coupled to the surface of small unilamellar vesicles. In addition, conformational data obtained by the circular dichroism technique have shown a decrease in the helical contribution of peptide-once linked to phospholipid; probably this change is due to the restriction introduced at the N-terminus of the sequence when coupled to the derivatized phospholipids at the surface of vesicle bilayers.

[1]  A. Bosch,et al.  Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus , 1998, FEBS letters.

[2]  S. Croft,et al.  Liposomal amphotericin B in drug-resistant visceral leishmaniasis , 1991, The Lancet.

[3]  N. Greenfield.  Methods to estimate the conformation of proteins and polypeptides from circular dichroism data. , 1996, Analytical biochemistry.

[4]  B. Barber,et al.  Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC , 1987, Nature.

[5]  T. Allen,et al.  Liposomes , 2012, Drugs.

[6]  R. New,et al.  Liposomes : a practical approach , 1990 .

[7]  A. Bosch,et al.  A new continuous epitope of hepatitis A virus , 1998, Journal of medical virology.

[8]  D. Altschuh,et al.  Uses of biosensors in the study of viral antigens. , 1997, Immunological investigations.

[9]  S. Cryz,et al.  Immunogenicity of new virosome influenza vaccine in elderly people , 1994, The Lancet.

[10]  R. Wohlhueter,et al.  Analysis of binding of monoclonal antibody to a malarial peptide by surface plasmon resonance biosensor and integrated rate equations. , 1994, Journal of immunology.

[11]  M. Bergeron,et al.  Liposomes as drug delivery system: a strategic approach for the treatment of HIV infection. , 1998, Journal of drug targeting.

[12]  C. Redemann,et al.  Synthesis of carboxyacyl derivatives of phosphatidylethanolamine and use as an efficient method for conjugation of protein to liposomes. , 1986, Biochimica et biophysica acta.

[13]  A. Bosch,et al.  Anti‐Hepatitis A Virus Antibody Response Elicited in Mice by Different Forms of a Synthetic VP1 Peptide , 1995, Microbiology and immunology.

[14]  C. W. McClare,et al.  An accurate and convenient organic phosphorus assay. , 1971, Analytical biochemistry.

[15]  I. Haro,et al.  Synthesis, lipophilic derivatization and interaction with liposomes of HAV-VP3 (102-121) sequence by using spectroscopic techniques. , 1996, The Analyst.

[16]  F. Martin,et al.  Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting. , 1982, The Journal of biological chemistry.

[17]  F. Hudecz,et al.  Analysis of the interaction with biomembrane models of the HAV-VP3(101-121) sequence conjugated to synthetic branched chain polypeptide carriers with a poly[L-lysine] backbone , 1998 .